Psychopharmacological Decision Making in Bipolar Disorder During Pregnancy and Lactation: A Case-by-Case Approach to Using Current Evidence
Authors:
- 1 July 2019
- journal article
- review article
- Published by American Psychiatric Association Publishing in FOCUS
- Vol. 17 (3) , 249-258
Abstract
The safety of pharmacotherapy for bipolar disorder during pregnancy and lactation remains a subject of debate and uncertainty. Clinicians must balance concerns about anatomical and behavioral teratogenicity, maternal mental health, exposure to multiple drugs, and heightened risks for peripartum mood episodes. Risk-benefit analyses must consider factors such as illness severity, past pregnancy treatment outcomes, known drug responsivity, psychosocial supports, and key windows during fetal development. Pharmacological decision making usually changes over the course of pregnancy, given developments in maternal physiology and critical relapse risk periods. Among mood stabilizers, given current research, many experts eschew divalproex and carbamazepine, consider lamotrigine relatively benign, and voice strong opinions for or against lithium. Most second-generation antipsychotics are considered relatively safe, apart from possible extrapyramidal and other motor signs of withdrawal after delivery. In this review, the authors analyze the practical questions, current controversies, and available evidence regarding psychotropic drug therapy during pregnancy and lactation in bipolar disorder.Keywords
This publication has 79 references indexed in Scilit:
- Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort studyBMJ Open, 2013
- Interpersonal Psychotherapy for Postpartum DepressionClinical Psychology & Psychotherapy, 2012
- Nonpharmacologic Intervention and Prevention Strategies for Depression During Pregnancy and the PostpartumClinical Obstetrics and Gynecology, 2009
- The Management of Depression During Pregnancy: A Report from the American Psychiatric Association and the American College of Obstetricians and GynecologistsObstetrics & Gynecology, 2009
- Lithium Placental Passage and Obstetrical Outcome: Implications for Clinical Management During Late PregnancyAmerican Journal of Psychiatry, 2005
- Anticonvulsants and Breast FeedingPediatric Drugs, 2000
- ECT-Induced Premature LaborThe Journal of Clinical Psychiatry, 1999
- Cleft Palate and Open Eyelids Inducing Activity of Lorazepam and the Effect of Flumazenil, the Benzodiazepine AntagonistBasic & Clinical Pharmacology & Toxicology, 1994
- Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feedingEuropean Journal of Pediatrics, 1990
- Lack of Relation of Oral Clefts to Diazepam Use during PregnancyNew England Journal of Medicine, 1983